Pfizer (PFE) Tax Expense: History & Chart

Pfizer Inc.(PFE)

Drug Manufacturers - General · New York City, NY

$27.78+0.00 (+0.00%)

Delayed quote: Sep 9, 2026, 4:02 PM EDT

About Pfizer Inc.

Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.

New York City, NY

75,000 employees

www.pfizer.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Albert Bourla

View full financials

Income Tax Expense

The latest quarterly tax expense is −$407.00 Million. Income tax expense is the amount a company pays in federal, state, and foreign income taxes based on its taxable income for the period.

EBT|Net Income|Free Cash Flow|Revenue|Income Statement

Tax Expense

PFE Tax Expense

$-407.00M

Reported quarterly tax expense; no daily interpolation. Quarter ended Jun 2026 (2026-06-28): $-407.00M.

-243.31% over 10Y

Current Tax Expense

−$407.00M

−$407.00 Million

QoQ Growth

N/A

Historical Data

Quarters of data available

Quarterly Tax Expense History

Period	Tax Expense	QoQ Growth	YoY Growth
Quarter ended Jun 2026Period end 2026-06-28	−$407.00M	N/A	N/A
Quarter ended Mar 2026Period end 2026-03-29	$461.00M	N/A	N/A
Quarter ended Dec 2025Period end 2025-12-31	−$2.00M	N/A	N/A
Quarter ended Sep 2025Period end 2025-09-28	−$216.00M	N/A	N/A
Quarter ended Jun 2025Period end 2025-06-29	$141.00M	N/A	N/A
Quarter ended Mar 2025Period end 2025-03-30	−$189.00M	N/A	N/A
Quarter ended Dec 2024Period end 2024-12-31	−$421.00M	N/A	N/A
Quarter ended Sep 2024Period end 2024-09-29	$234.00M	N/A	N/A
Quarter ended Jun 2024Period end 2024-06-30	−$134.00M	N/A	N/A
Quarter ended Mar 2024Period end 2024-03-31	$293.00M	N/A	N/A
Quarter ended Dec 2023Period end 2023-12-31	−$794.00M	N/A	N/A
Quarter ended Oct 2023Period end 2023-10-01	−$964.00M	N/A	N/A
Quarter ended Jul 2023Period end 2023-07-02	−$71.00M	N/A	N/A
Quarter ended Apr 2023Period end 2023-04-02	$715.00M	N/A	N/A
Quarter ended Dec 2022Period end 2022-12-31	$230.00M	N/A	N/A
Quarter ended Oct 2022Period end 2022-10-02	$356.00M	N/A	N/A
Quarter ended Jul 2022Period end 2022-07-03	$1.57B	N/A	N/A
Quarter ended Apr 2022Period end 2022-04-03	$1.17B	N/A	N/A
Quarter ended Dec 2021Period end 2021-12-31	$249.00M	N/A	N/A
Quarter ended Oct 2021Period end 2021-10-03	−$328.00M	N/A	N/A
Quarter ended Jul 2021Period end 2021-07-04	$1.12B	N/A	N/A
Quarter ended Apr 2021Period end 2021-04-04	$808.00M	N/A	N/A
Quarter ended Dec 2020Period end 2020-12-31	−$80.00M	N/A	N/A
Quarter ended Sep 2020Period end 2020-09-27	−$347.00M	N/A	N/A
Quarter ended Jun 2020Period end 2020-06-28	$422.00M	N/A	N/A
Quarter ended Mar 2020Period end 2020-03-29	$359.00M	N/A	N/A
Quarter ended Dec 2019Period end 2019-12-31	−$1.18B	N/A	N/A
Quarter ended Sep 2019Period end 2019-09-29	$3.05B	N/A	N/A
Quarter ended Jun 2019Period end 2019-06-30	−$915.00M	N/A	N/A
Quarter ended Mar 2019Period end 2019-03-31	$433.00M	N/A	N/A
Quarter ended Dec 2018Period end 2018-12-31	−$563.00M	N/A	N/A
Quarter ended Sep 2018Period end 2018-09-30	$66.00M	N/A	N/A
Quarter ended Jul 2018Period end 2018-07-01	$648.00M	N/A	N/A
Quarter ended Apr 2018Period end 2018-04-01	$556.00M	N/A	N/A
Quarter ended Dec 2017Period end 2017-12-31	−$11.34B	N/A	N/A
Quarter ended Oct 2017Period end 2017-10-01	$727.00M	N/A	N/A
Quarter ended Jul 2017Period end 2017-07-02	$739.00M	N/A	N/A
Quarter ended Apr 2017Period end 2017-04-02	$821.00M	N/A	N/A
Quarter ended Dec 2016Period end 2016-12-31	$14.00M	N/A	N/A
Quarter ended Oct 2016Period end 2016-10-02	$284.00M	N/A	N/A
Quarter ended Jul 2016Period end 2016-07-03	$375.00M	N/A	N/A
Quarter ended Apr 2016Period end 2016-04-03	$535.00M	N/A	N/A
Quarter ended Dec 2015Period end 2015-12-31	−$188.00M	N/A	N/A
Quarter ended Sep 2015Period end 2015-09-27	$567.00M	N/A	N/A
Quarter ended Jun 2015Period end 2015-06-28	$905.00M	N/A	N/A
Quarter ended Mar 2015Period end 2015-03-29	$706.00M	N/A	N/A
Quarter ended Dec 2014Period end 2014-12-31	$545.00M	N/A	N/A
Quarter ended Sep 2014Period end 2014-09-28	$911.00M	N/A	N/A
Quarter ended Jun 2014Period end 2014-06-29	$1.08B	N/A	N/A
Quarter ended Mar 2014Period end 2014-03-30	$582.00M	N/A	N/A
Quarter ended Dec 2013Period end 2013-12-31	$430.00M	N/A	N/A
Quarter ended Sep 2013Period end 2013-09-29	$985.00M	N/A	N/A
Quarter ended Jun 2013Period end 2013-06-30	$1.78B	N/A	N/A
Quarter ended Mar 2013Period end 2013-03-31	$1.16B	N/A	N/A
Quarter ended Dec 2012Period end 2012-12-31	$680.00M	N/A	N/A
Quarter ended Sep 2012Period end 2012-09-30	−$119.00M	N/A	N/A
Quarter ended Jul 2012Period end 2012-07-01	$1.29B	N/A	N/A
Quarter ended Apr 2012Period end 2012-04-01	$750.00M	N/A	N/A
Quarter ended Dec 2011Period end 2011-12-31	$800.00M	N/A	N/A
Quarter ended Oct 2011Period end 2011-10-02	$1.24B	N/A	N/A
Quarter ended Jul 2011Period end 2011-07-03	$1.09B	N/A	N/A
Quarter ended Apr 2011Period end 2011-04-03	$894.00M	N/A	N/A
Quarter ended Dec 2010Period end 2010-12-31	−$2.07B	N/A	N/A
Quarter ended Oct 2010Period end 2010-10-03	$564.00M	N/A	N/A
Quarter ended Jul 2010Period end 2010-07-04	$1.49B	N/A	N/A
Quarter ended Apr 2010Period end 2010-04-04	$1.15B	N/A	N/A
Quarter ended Dec 2009Period end 2009-12-31	−$755.00M	N/A	N/A
Quarter ended Sep 2009Period end 2009-09-27	$1.09B	N/A	N/A
Quarter ended Jun 2009Period end 2009-06-28	$786.00M	N/A	N/A
Quarter ended Mar 2009Period end 2009-03-29	$1.07B	N/A	N/A
Quarter ended Dec 2008Period end 2008-12-31	$394.00M	N/A	N/A
Quarter ended Sep 2008Period end 2008-09-28	$463.00M	N/A	N/A
Quarter ended Jun 2008Period end 2008-06-29	$25.00M	N/A	N/A
Quarter ended Mar 2008Period end 2008-03-30	$763.00M	N/A	N/A
Quarter ended Dec 2007Period end 2007-12-31	$223.00M	N/A	N/A
Quarter ended Sep 2007Period end 2007-09-30	−$161.00M	N/A	N/A
Quarter ended Jul 2007Period end 2007-07-01	$272.00M	N/A	N/A
Quarter ended Apr 2007Period end 2007-04-01	$689.00M	N/A	N/A
Quarter ended Dec 2006Period end 2006-12-31	$223.00M	N/A	N/A
Quarter ended Oct 2006Period end 2006-10-01	$717.00M	N/A	N/A
Quarter ended Jul 2006Period end 2006-07-02	$790.00M	N/A	N/A
Quarter ended Apr 2006Period end 2006-04-02	$315.00M	N/A	N/A
Quarter ended Dec 2005Period end 2005-12-31	$609.00M	N/A	N/A
Quarter ended Oct 2005Period end 2005-10-02	$591.00M	N/A	N/A
Quarter ended Jul 2005Period end 2005-07-03	−$413.00M	N/A	N/A
Quarter ended Apr 2005Period end 2005-04-03	$2.63B	N/A	N/A
Quarter ended Dec 2004Period end 2004-12-31	$625.00M	N/A	N/A
Quarter ended Sep 2004Period end 2004-09-26	$650.00M	N/A	N/A
Quarter ended Jun 2004Period end 2004-06-27	$582.00M	N/A	N/A
Quarter ended Mar 2004Period end 2004-03-28	$809.00M	N/A	N/A
Quarter ended Dec 2003Period end 2003-12-31	$335.00M	N/A	N/A
Quarter ended Sep 2003Period end 2003-09-28	$253.00M	N/A	N/A
Quarter ended Jun 2003Period end 2003-06-29	$270.00M	N/A	N/A
Quarter ended Mar 2003Period end 2003-03-30	$764.00M	N/A	N/A
Quarter ended Dec 2002Period end 2002-12-31	$628.00M	N/A	N/A
Quarter ended Sep 2002Period end 2002-09-29	$680.00M	N/A	N/A

Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.

Data as of June 28, 2026